These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10408635)
1. Contribution of zinc to reduce CD4+ risk factor for 'severe' infection relapse in aging: parallelism with HIV. Mocchegiani E; Muzzioli M; Gaetti R; Veccia S; Viticchi C; Scalise G Int J Immunopharmacol; 1999 Apr; 21(4):271-81. PubMed ID: 10408635 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections. Mocchegiani E; Muzzioli M J Nutr; 2000 May; 130(5S Suppl):1424S-31S. PubMed ID: 10801955 [TBL] [Abstract][Full Text] [Related]
3. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mocchegiani E; Muzzioli M; Giacconi R; Cipriano C; Gasparini N; Franceschi C; Gaetti R; Cavalieri E; Suzuki H Mech Ageing Dev; 2003 Apr; 124(4):459-68. PubMed ID: 12714254 [TBL] [Abstract][Full Text] [Related]
4. The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial. Hadadi A; Ostovar A; Edalat Noor B; Rasoolinejad M; Haji Abdolbaghi M; Yousefi S; Khalili H; Manshoori G; Khashayar P; Alipour Z; Safari N Acta Clin Belg; 2020 Jun; 75(3):170-176. PubMed ID: 30888253 [No Abstract] [Full Text] [Related]
5. Nutritional and immunological status and their associations among HIV-infected adults in Addis Ababa, Ethiopia. Fufa H; Umeta M; Taffesse S; Mokhtar N; Aguenaou H Food Nutr Bull; 2009 Sep; 30(3):227-32. PubMed ID: 19927602 [TBL] [Abstract][Full Text] [Related]
6. Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. Lapadula G; Torti C; Maggiolo F; Casari S; Suter F; Minoli L; Pezzoli C; Di Pietro M; Migliorino G; Ouiros-Roldan E; Ladisa N; Sighinolfi L; Costarelli S; Carosi G; Antivir Ther; 2007; 12(6):941-7. PubMed ID: 17926648 [TBL] [Abstract][Full Text] [Related]
7. Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients. Rousseau MC; Molines C; Moreau J; Delmont J Ann Nutr Metab; 2000; 44(5-6):212-6. PubMed ID: 11146326 [TBL] [Abstract][Full Text] [Related]
8. Thymic function in HIV-infection. Kolte L Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726 [TBL] [Abstract][Full Text] [Related]
10. Zinc status in HIV infected Ugandan children aged 1-5 years: a cross sectional baseline survey. Ndeezi G; Tumwine JK; Bolann BJ; Ndugwa CM; Tylleskär T BMC Pediatr; 2010 Sep; 10():68. PubMed ID: 20858275 [TBL] [Abstract][Full Text] [Related]
11. Zinc status in human immunodeficiency virus type 1 infection and illicit drug use. Baum MK; Campa A; Lai S; Lai H; Page JB Clin Infect Dis; 2003; 37 Suppl 2():S117-23. PubMed ID: 12942385 [TBL] [Abstract][Full Text] [Related]
12. Selected micronutrient levels and response to highly active antiretroviral therapy (HAART) among HIV/AIDS patients attending a teaching Hospital in Addis Ababa, Ethiopia. Eshetu A; Tsegaye A; Petros B Biol Trace Elem Res; 2014 Dec; 162(1-3):106-12. PubMed ID: 25256923 [TBL] [Abstract][Full Text] [Related]
14. Low plasma zinc levels and immunological responses to zinc supplementation in HIV-infected patients with immunological discordance after antiretroviral therapy. Asdamongkol N; Phanachet P; Sungkanuparph S Jpn J Infect Dis; 2013; 66(6):469-74. PubMed ID: 24270132 [TBL] [Abstract][Full Text] [Related]
15. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ; Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251 [TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects. De Milito A; Aleman S; Marenzi R; Sonnerborg A; Fuchs D; Zazzi M; Chiodi F Clin Exp Immunol; 2002 Mar; 127(3):486-94. PubMed ID: 11966765 [TBL] [Abstract][Full Text] [Related]
18. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235 [TBL] [Abstract][Full Text] [Related]
19. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study. McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741 [TBL] [Abstract][Full Text] [Related]
20. Oral zinc supplementation in the treatment of HIV-infected children. Reich EN; Church JA Pediatr AIDS HIV Infect; 1994 Dec; 5(6):357-60. PubMed ID: 11361377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]